Viral resistance is a major problem with current AIDS drugs. The feline immunodeficiency virus model may provide a way to test new drugs and strategies before human trials.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pedersen, N.C., Ho, E.M., Brown, M.L. & Yamamoto, J.K. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235, 790–793 (1987).
Pedersen, N.C. The feline immunodeficiency virus. in The Retroviridae Vol. 2 (ed. Levy, J.A.) 181–219 (Plenum Press, New York, 1993).
Ishida, T. & Tomoda, I. Clinical stages of feline immunodeficiency virus infection. Jpn. J. vet. Sci. 52, 645–648 (1990).
Ackley, C.D., Yamamoto, J.K., Levy, N., Pedersen, N.C. & Cooper, M.D. Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J. Virol. 64, 5652–5655 (1990).
English, R.V. et al. Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J. infec. Dis. 170, 543–552 (1994).
Barlough, J.E. et al. Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections. J. Acquir. Immune. Defic. Syndr. 4, 219–227 (1991).
Davidson, M.G., Rottman, J.B., English, R.V., Lapplin, M.R. & Tompkins, M.B. Feline immunodeficincy virus predisposes cats to acute generalized toxoplasmosis. Am. J. Pathol. 143, 1486–1497 (1993).
Podell, M. et al. AIDS-associated encephalopathy with experimental feline immunodeficiency virus infection. J. Acquir. Immune. Defic. Syndr. 6, 758–771 (1993).
Phillips, T.R. et al. Neurological abnormalities associated with feline immunodeficiency virus infection. J. gen. Virol. 75, 979–987 (1994).
Remington, K.M., Chesebro, B., Wehrly, K., Pedersen, N.C. & North, T.W. Mutants of feline immunodeficiency virus resistant to 3′-azido-3′-deoxythymidine. J. Virol. 65, 308–312 (1991).
Gobert, J.M., Remington, K.M., Zhu, Y.-Q. & North, T.W. Multiple drug-resistant mutants of feline immunodeficiency virus selected with 2′,3′-dideoxyinosine alone and in combination with 3′-azido-3′-deoxythymidine. Antimicrob. Agents Chemother. 38, 861–864 (1994).
Nowak, M.A. et al. Antigenic diversity thresholds and the development of AIDS. Science 254, 963–969 (1991).
Chesebro, B., Wehrly, K., Nishio, J. & Perryman, S. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homology in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J. Virol. 66, 6547–6554 (1992).
Wainberg, M.A. Clinical correlates and molecular basis of HIV drug resistance. J. Acquir. Immune Defic. Syndr. 6 (Suppl. 1), S36–S46 (1993).
Richman, D.D. Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents. Antimicrob. Agents Chemother. 37, 1207–1213 (1993).
Retrovir package insert, Burroughs Wellcome Co., Research Triangle Park, North Carolina (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
North, T., Lacasse, R. Testing anti–HIV drugs in the FIV model. Nat Med 1, 410–411 (1995). https://doi.org/10.1038/nm0595-410
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0595-410